International conferences and seminars

Orphan Drugs Research and Commercialization

GTC is proud to announce its inaugural Orphan Drugs Research and Commercialization Conference at a crucial time in the rare disease space. With new therapies emerging in rare disease treatment and exciting partnerships being forged between big pharma and smaller niche companies, it is clear that the field of rare diseases and orphan drugs is growing. Rather than merely reciting the challenges of orphan drug development, it is time all stakeholders in the community come together to find innovative solutions that will better serve rare disease patients.

This meeting connects industry, academia, regulators, and patient groups to dialogue about strategies to improve orphan drug research, pricing, reimbursement, access, and other key topics.

The Orphan Drugs Research and Commercialization Conference is part of the Drug Discovery Summit 2013 on May 8 - 10, 2013 at the Hyatt Regency in Boston, MA.

Tentative Sessions Include:

Novel Therapeutics in Rare Diseases
Designing Effective Clinical Trials Case Studies in the Preclinical and Clinical Space
Partnering in Rare Diseases
Commercialization of Orphan Drugs
Panel Discussion: Regulatory in Orphan Drug Development

To view the agenda, click here.
To view the speaker list, click here.

The conference will run parallel with the other exciting conferences:
8th Assay and Drug Discovery Technologies
8th Protein Kinases in Drug Discovery
7th Drug Design and Medicinal Chemistry
6th Imaging in Drug Discovery and Development conference

We look forward to seeing you at the conference!